This presentation explores the FGFR mutation study, outlining its significance in cancer research, the role of FGFR in tumorigenesis, and mutagenesis as a methodology. It delves into detailed mutation screening, differentiating activating from resistance mutations, and highlights drug-specific targets. Practical insights include resistance predictions, druggable mutations, and their clinical relevance. The session concludes with reflections on the study's impact on precision oncology and...